Gestasyonel Diyabette Genetik ve Epigenetik Değişimler
Gestasyonel Diyabet (GDM) ilk defa gebelikte teşhis edilen veya başlayan farklı derecelerdeki glukoz intöleransıdır. GDM tanısı alan
gebelerde ve yeni doğanda komplikasyon oranı artar. GDM için birçok risk faktörü tespit edilmiş olup bunlar ileri anne yaşı, yüksek
parite, önceki gebelikte GDM öyküsü, ya da makrozomik bebeğin erken doğumu, kısa boy, obezite, çoklu gebelik, gebelik sırasında
yüksek kan basıncı ve ailede diyabet öyküsüdür. GDM prevelansı farklı populasyonlar arasında değişkenlik göstermekte olup bu değer
% 7 ile % 17 arasında değişir. GDM sıklığının populasyonlar arasında değişkenlik göstermesinde, genetik ve epigenetik farklılıkların
önemli rolü olduğu düşünülmektedir.
GDM ile ilgili yapılan genetik çalışmaların çoğu biyolojik olarak makul olan aday gen analizlerine dayanmaktadır. Bu çalışmaların
birçoğunu içeren iki farklı meta-analiz gerçekleştirilmiş olup bu iki meta-analiz sonucunda GDM ile ilişki gösteren 8 gen tespit edilmiştir.
Bu genler; TCF7L2, GCK, KCNJ11, KCNQ1, CDKAL1, IGF2BP2, MTNR1B ve IRS1’dir. Bu lokusların/genlerin tümü aynı zamanda
Tip 2 Diyabet (T2DM) riski ile de ilişkilidir. GCK, KCNJ11, KCNQ1, MTNR1B, IGF2BP2, CDKAL1 ve TCF7L2’nin de dahil olduğu
bu genlerin çoğunluğu, beta hücre fonksiyonu veya gelişimi için önemli olan proteinleri kodlamaktadır. Bunun yanı sıra epigenetik
faktörlerin de GDM patogenezinde oldukça önemli rol oynadığını gösteren kanıtlar mevcuttur. Bu makalede GDM patogenezinde rolü
olduğu düşünülen genetik ve epigenetik faktörler sunulmuştur.
Genetic and Epigenetic Alterations in Gestational Diabetes
Gestational Diabetes is glucose intolerance that are diagnosed or started for the first time in pregnancy. In pregnancies diagnosed withgestational diabetes mellitus, complication rates increase in mother and newborn. Many risk factors have been identified for GDM.These include anemia, advanced maternal age, high parity, GDM in previous gestation, or premature birth of macrosomic baby, shortstature, obesity, multiple gestation, high blood pressure during pregnancy and family history of diabetes. The prevalence of GDM variesbetween different populations, with prevalence ranging from 7% to 17% in different populations. There is important role of genetic andepigenetic differences in variability of GDM prevalence between populations.Most of the genetic studies on GDM focus on biologically plausible candidate gene analyzes. Two different meta-analyzes involving amajority of these studies were performed, and these meta-analyzes revealed 8 genes associated with GDM. These genes are; TCF7L2,GCK, KCNJ11, KCNQ1, CDKAL1, IGF2BP2, MTNR1B and IRS1. All of these locations are also related to the T2DM risk. The majorityof these genes, including GCK, KCNJ11, KCNQ1, MTNR1B, IGF2BP2, CDKAL1 and TCF7L2, encode proteins that are important forbeta cell function or development. There is also evidence that epigenetic factors play an important role in the pathogenesis of GDM. Inthis article, genetic and epigenetic factors thought to play a role in the pathogenesis of GDM are presented.
___
- 1. Löbner K, et al. Predictors of postpartum diabetes in women
with gestational diabetes mellitus. Diabetes. 2006;55(3):792-
797.
- 2. Ashwal E, Hod M. Gestational diabetes mellitus: Where are we
now? Clin Chim Acta. 2015; 451:14-20.
- 3. Buchanan TA, et al. What is gestational diabetes? Diabetes
Care. 2007;30:105–111.
- 4. Buchanan TA, et al. Gestational diabetes mellitus:risks and
management during and after pregnancy. Nat Rev Endocrinol.
2012;8:639–649.
- 5. Dabelea D, et al. Kaiser Permanente of Colorado GDMSP,
increasing prevalence of gestational diabetes mellitus (GDM)
over time and by birth cohort: Kaiser Permanente of Colorado
GDM screening program. Diabetes Care. 2005;28:579–584.
- 6. Ferrara A, et al. An increase in the incidence of gestational
diabetes mellitus: Northern California, 1991-2000. Obstet
Gynecol. 2004;103:526–533.
- 7. Butler AE, et al. Adaptive changes in pancreatic beta cell
fractional area and beta cell turnover in human pregnancy.
Diabetologia. 2010;53: 2167–2176.
- 8. Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin
Obstet Gynecol. 2007;50:938–948.
- 9. Bajaj K, Gross SJ. The genetics of diabetic pregnancy. Best
Pract Res Clin Obstet Gynaecol. 2015;29(1):102-109.
- 10. Genetics and Health. World Health Organization. (http://www.
who.int/rpc/genomics_report.pdf. Accessed Date 19.10.2017)
- 11. Williams MA, et al. Familial aggregation of Type 2 diabetes
and chronic hypertension in women with gestational diabetes
mellitus. J Reprod Med. 2003;48(12):955e62.
- 12. Practice Bulletin No. 137. Gestational diabetes mellitus. Obstet
Gynecol. 2013;122(2 Pt 1): 406-416.
- 13. Galtier F. Definition, epidemiology, risk factors. Diabetes
Metab. 2010;36(6 Pt 2):628-651.
- 14. Lowe WL Jr, et al. Gestational diabetes mellitus, programing
and epigenetics, Jie Yan and Huixia Yang. Curr Diab Rep.
2016;16(2):15.
- 15. Korte A, Farlow A. The advantages and limitations of trait
analysis with GWAS: A review. Plant Methods. 2013;9(1):29.
- 16. Mao H, et al. Meta-analysis of the relationship between
common type 2 diabetes risk gene variants with gestational
diabetes mellitus. PLoS One. 2012;7:e45882.
- 17. Zhang C, et al. Genetic variants and the risk of gestational
diabetes mellitus: A systematic review. Hum Reprod Update.
2013;19:376–390.
- 18. Morris AP, et al. Diabetes Genetics Replication and Metaanalysis
(DIAGRAM) Consortium. Large-scaleassociationanalysisprovidesinsightsintothegeneticarchitectureandpathophysiology
of type 2 diabetes. NatGenet. 2012;44:981–990.
- 19. Basile KJ, et al. Genetic susceptibility to type 2 diabetes and
obesity: Follow-up of findings from genomewide association
studies. Int J Endocrinol. 2014;2014:769671.
- 20. Mohlke KL, Boehnke M. Recent advances in understanding
the genetic architecture of type 2 diabetes. Hum Mol Genet.
2015;24: R85–92.
- 21. Dimas AS, et al. Impact of type 2 diabetes susceptibility
variants on quantitative glycemic traits reveals mechanistic
heterogeneity. Diabetes. 2014;63:2158–2171.
- 22. Kurokawa N, et al. The ADRB3 Trp64Arg variant and BMI:
A meta-analysis of 44 833 individuals. Int J Obes (Lond).
2008;32:1240–1249.
- 23. Stuebe AM, et al. Maternal genotype and gestational diabetes.
Am J Perinatol. 2014;31:69–76.
- 24. IrwinDM, Tan H. Evolution of glucose utilization: Glucokinase
and glucokinase regulator protein. Mol Phylogenet Evol.
2014;70:195–203.
- 25. Huopio H, et al. Association of risk variants for type 2 diabetes
and hyperglycemia with gestational diabetes. Eur J Endocrinol.
2013;169:291–297.
- 26. Huerta-Chagoya A, et al. Genetic determinants for gestational
diabetes mellitus and related metabolic traits in Mexican
women. PLoS One. 2015;10:e0126408.
- 27. Grant SF, et al. Variant of transcription factor 7-like 2
(TCF7L2) gene confers risk of type 2 diabetes. Nat Genet.
2006;38(3):320e3.
- 28. Florez JC, et al. Diabetes Prevention Program Research Group.
TCF7L2 polymorphisms and progression to diabetes in the
diabetes prevention program. N Engl J Med. 2006;355(3):241-
250.
- 29. Kang S, et al. Association of the rs7903146 polymorphism in
transcription factor 7-like 2 (TCF7L2) gene with gestational
diabetes mellitus: A meta-analysis. Gynecol Endocrinol.
2013;29(10):873e7.
- 30. Li Q, et al. KCNJ11 E23K variant is associated with the
therapeutic effect of sulphonylureas in Chinese type 2 diabetic
patients. Clin Exp Pharmacol Physiol. 2014;41:748–754.
- 31. Maruthur NM, et al.The pharmacogenetics of type 2 diabetes:
A systematic review. Diabetes Care. 2014;37:876–886.
- 32. Desoye G, Hauguel-de Mouzon S. The human placenta in
gestational diabetesmellitus. The insulin and cytokine network.
Diabetes Care. 2007;30(2):120–126.
- 33. Newbern D, Freemark M. Placental hormones and the
control of maternal metabolism and fetal growth. Curr Opin
Endocrinol Diabet Obes. 2011;18:409–416.
- 34. Lowe LP, et al. Inflammatory mediators and glucose in
pregnancy: Results from a subset of the hyperglycemia and
adverse pregnancy outcome (HAPO) study. J Clin Endocrinol
Metab. 2010;95: 5427–5434.
- 35. Urbanek M, et al. The role of inflammatory pathway
genetic variation on maternal metabolic phenotypes during
pregnancy. PLoS One. 2012;7:e32958.
- 36. Guzmán-Flores JM, et al. Association analysis between -308G/
A and -238G/A TNF-alpha gene promoter polymorphisms
and insulin resistance in Mexican women with gestational
diabetes mellitus. J Investig Med. 2013;61:265–269.
- 37. Kwak SH, et al. A genome-wide association study of gestational
diabetes mellitus in Korean women. Diabetes. 2012;61:531–
541.
- 38. Yan J, Yang H. Gestational diabetes mellitus, programing and
epigenetics. J Matern Fetal Neonatal Med. 2014;27(12):1266-
1269.
- 39. Ling C, et al. Epigenetic regulation of PPARGC1A in
human type 2 diabetic islets and effect on insülin secretion.
Diabetologia. 2008;51:615–622.
- 40. Park JH, et al. Development of type 2 diabetes following
intrauterine growth retardation in rats is associated with
progressive epigenetic silencing of Pdx1. J Clin Invest.
2008;118:2316–2324.
- 41. Baker J, et al. Role of insulin-like growth factors in embryonic
and postnatal growth. Cell. 1993;75:73–82.
- 42. Tobi EW, et al. DNA methylation differences after exposure
to prenatal famine are common and timing- and sex-specific.
Hum Mol Genet. 2009;18:4046–4053.
- 43. Painter RC, et al. Transgenerational effects of prenatal exposure
to the Dutch famine on neonatal adiposity and health in later
life. BJOG. 2008;115:1243–1249.
- 44. Simmons RA, et al. Intrauterine growth retardation leads
to the development of type 2 diabetes in the rat. Diabetes.
2001;50:2279–2286.
- 45. Ng SF, et al. Chronic high-fat diet in fathers programs beta-cell
dysfunction in female rat offspring. Nature. 2010;467:963–966.
- 46. Zhao C, et al. Early second-trimester serum MiRNA
profiling predicts gestational diabetes mellitus. PLoS ONE.
2011;6(8):e23925.
- 47. Collares CV, et al. Identifying common and specific
microRNAs expressed in peripheral blood mononuclear cell
of type 1, type 2, and gestational diabetes mellitus patients.
BMC Res Notes. 2013;6:491.
- 48. Pillar N, et al. The possible involvement of microRNAs in
preeclampsia and gestational diabetes mellitus. Best Pract Res
Clin Obstet Gynaecol. 2015;29(2):176-182.